FIELD: chemistry of proteins. SUBSTANCE: invention describes novel compounds of the general formula (I): X1-His-Gly-X2-His-Gly-Val-X3 or their pharmaceutically acceptable salts, or esters, or amides where X1 is absent or has at least one amino acids; X2 has at least one amino acid or means a peptide bond; X3 is absent or has at least one amino acid being indicated amino acids are taken among aliphatic, aromatic or heterocyclic group. Compounds stimulate antiviral, antibacterial and antitumor activity of human immune system. EFFECT: new peptides indicated above, valuable medicinal properties. 7 cl, 17 tbl, 2 dwg _
Title | Year | Author | Number |
---|---|---|---|
ANTI-TUMOR AND ANTIVIRAL PEPTIDES | 2004 |
|
RU2267496C2 |
AGENT FOR EXTERNAL APPLICATION, POSSESSING ANTIVIRAL ACTIVITY | 2006 |
|
RU2338553C2 |
METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
METHOD OF TREATING PAPILLOMA VIRAL INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN-18 INDUCTION | 2010 |
|
RU2482866C2 |
COMPOSITION FOR PREPARATION OF ANTI-TUMOR MEDICATION AND METHOD FOR PREPARATION OF ANTI-TUMOR MEDICATION BASED ON IT | 2016 |
|
RU2667128C2 |
METHOD OF PRODUCING A DRUG BASED ON OLIGOPEPTIDE ALLOFERON-1, HAVING AN ANTIVIRAL AND IMMUNOMODULATING EFFECT, AND PROLONGED STORAGE MEDICINAL PRODUCT OBTAINED WITH ITS HELP | 2017 |
|
RU2737852C2 |
BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOFERON-1 | 2013 |
|
RU2576830C2 |
CYCLOFERON-CONTAINING MEDICINAL AGENT, METHOD FOR ITS PREPARING AND USING | 2005 |
|
RU2281097C1 |
ANTIVIRAL SUBSTANCE | 2004 |
|
RU2276988C2 |
IMMUNOMODULATOR WITH ANTITUMOR ACTIVITY AND DRUG BASED ON THE SAME | 2005 |
|
RU2283663C1 |
Authors
Dates
2001-08-20—Published
1999-12-27—Filed